Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 20,977-20,988 of 23,847
Biological study icon
CompletedNCT02449746

Immunotherapy in Autoantibody Positive Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
SchizophreniaBiologicalFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
University of Cambridge
Condition
Schizophrenia
Drug study icon
TerminatedNCT06374290

Injectable Naltrexone and Oral Bupropion Among Cigarette Smokers With Schizophrenia

This study exists to see whether the medication Injectable is workable and worth testing more broadly. Researchers are trying to understand how people respond to the medication Injectable in practice and what may need to be adjusted.

In Houston
SchizophreniaDrugA study involving a medication or substance.Over 18 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Schizophrenia
Other study type icon
CompletedNCT02170467

Intestinal Permeability in people with Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Bois-Guillaume
Eating disordersOtherFrom 18 Years to 50 Years
Countries
France
Sponsor
University Hospital, Rouen
Condition
Eating disorders
Drug study icon
CompletedNCT00107939

Licarbazepine in the Treatment of manic episodes of Bipolarity

This study exists to see whether the medication Licarbazepine can play a useful role in care. Researchers are trying to understand how people respond to the medication Licarbazepine in practice and what may need to be adjusted.

Multiple locations, including Little Rock
BipolarityDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Novartis Pharmaceuticals
Condition
Bipolarity
Drug study icon
CompletedNCT00107926

Licarbazepine in the Treatment of manic episodes of Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including La Palma
BipolarityDrugFrom 18 Years to 70 Years
Countries
United States, Canada, Austria, ...
Sponsor
Novartis Pharmaceuticals
Condition
Bipolarity
Drug study icon
CompletedNCT01731119

Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

This study exists to see whether the medication Lurasidone is workable and worth testing more broadly. Researchers are trying to understand whether the medication Lurasidone can give earlier or clearer feedback during care.

In Chapel Hill
Schizophrenia, Bipolarity, ...DrugFrom 6 Years to 19 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Schizophrenia, Bipolarity, ...
Device study icon
CompletedNCT03064776

m-RESIST, an m-Health Program for Treatment-resistant Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Budapest
SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 45 Years
Countries
Hungary, Israel, Spain
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.